165 related articles for article (PubMed ID: 26173466)
1. Herpes zoster: a potential risk associated with fingolimod treatment.
Mayor Ibarguren A; Gómez Fernández C; Tallón Barranco A; Fernández Fournier M; González Ramos J; Romero Gómez MP; Herranz Pinto P
Int J Dermatol; 2015 Sep; 54(9):e373-5. PubMed ID: 26173466
[No Abstract] [Full Text] [Related]
2. Polydermatomal perineal and gluteal herpes zoster infection in a patient on fingolimod treatment.
Kawiorski MM; Viedma-Guiard E; Costa-Frossard L; Corral I
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):138-9. PubMed ID: 24958672
[No Abstract] [Full Text] [Related]
3. [Fingolimod].
Hashi Y; Kondo T
Nihon Rinsho; 2015 Sep; 73 Suppl 7():205-11. PubMed ID: 26480701
[No Abstract] [Full Text] [Related]
4. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis.
Gündüz T; Kürtüncü M; Eraksoy M
Mult Scler Relat Disord; 2017 Jan; 11():1-3. PubMed ID: 28104247
[No Abstract] [Full Text] [Related]
5. Herpes zoster laryngitis in a patient treated with fingolimod.
Hagiya H; Yoshida H; Shimizu M; Motooka D; Nakamura S; Iida T; Yamamoto N; Akeda Y; Tomono K
J Infect Chemother; 2016 Dec; 22(12):830-832. PubMed ID: 27553068
[TBL] [Abstract][Full Text] [Related]
6. Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept.
Tresch S; Trueb RM; Kamarachev J; French LE; Hofbauer GF
Dermatology; 2009; 219(4):347-9. PubMed ID: 19648728
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.
Chong I; Wang KY; Lincoln CM
Clin Imaging; 2019; 54():53-56. PubMed ID: 30544079
[TBL] [Abstract][Full Text] [Related]
8. [Effect of valociclovir hydrochloride on patients with herpes zoster].
Li C; Liu Z
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):Inside back cover. PubMed ID: 12080735
[No Abstract] [Full Text] [Related]
9. [The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod].
Tanaka M
Rinsho Shinkeigaku; 2016 Apr; 56(4):270-2. PubMed ID: 27010095
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events.
Fragoso YD
Acta Neurol Belg; 2017 Dec; 117(4):821-827. PubMed ID: 28528469
[TBL] [Abstract][Full Text] [Related]
11. Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
Fragoso YD; Adoni T; Gomes S; Goncalves MV; Matta AP; Mendes MF; Siquineli F
Headache; 2015 Apr; 55(4):578-9. PubMed ID: 25754576
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
[TBL] [Abstract][Full Text] [Related]
13. [Herpes zoster of the maxillary branch of the trigeminal nerve].
Sterkers Y; Botterel F; Nicolas M; Bourée P
Presse Med; 2002 Aug; 31(27):1270. PubMed ID: 12238275
[No Abstract] [Full Text] [Related]
14. Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Artemiadis AK; Nikolaou G; Kolokythopoulos D; Tegos N; Terentiou A; Triantafyllou N; Papanastasiou I
Mult Scler; 2015 May; 21(6):795-6. PubMed ID: 25432949
[No Abstract] [Full Text] [Related]
15. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
16. Famous.
Kim MJ; Bhatti MT; Costello F
Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
[TBL] [Abstract][Full Text] [Related]
17. [Drug of the month. Valaciclovir (Zelitrex)].
Piérard GE; Nikkels AF
Rev Med Liege; 1997 Aug; 52(8):553-5. PubMed ID: 9381007
[No Abstract] [Full Text] [Related]
18. Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Harrer A; Wipfler P; Pilz G; Oppermann K; Haschke-Becher E; Afazel S; Kraus J; Trinka E; Sellner J
Int J Mol Sci; 2015 Sep; 16(9):21832-45. PubMed ID: 26378517
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.
Paolicelli D; Manni A; Direnzo V; D'Onghia M; Tortorella C; Zoccolella S; Trojano M
J Clin Pharmacol; 2015 Oct; 55(10):1131-6. PubMed ID: 25903516
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Thoo S; Cugati S; Lee A; Chen C
Mult Scler; 2015 Feb; 21(2):249-51. PubMed ID: 24696055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
